Patents-Review.com
🔗 Permalink
Assignee profile:

BioElectron Technology Corporation

City:

Mountain View, California

Country:

United States

Published Applications:

15

Last publication date:

2018-11-08

Patent Grants:

13

Last grant date:

2019-02-12

Top Inventors for applications by BioElectron Technology Corporation

These are the the leading inventors for applications assigned to BioElectron Technology Corporation:

Recent patent applications by BioElectron Technology Corporation

BioElectron Technology Corporation based in Mountain View, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-11-08 ✅ Patent 10,202,325 granted on 2019-02-12
US20180319730A1
Chemistry; metallurgy

Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols

 #2 | 2018-10-25
US20180303770A1
Human necessities

TREATMENT OF METHYLMALONIC ACIDURIA, ISOVALERIC ACIDURIA, AND OTHER ORGANIC ACIDURIAS WITH TOCOTRIENOL QUINONES

 #3 | 2018-10-25
US20180303767A1
Human necessities

TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS

 #4 | 2018-01-04 ✅ Patent 10,251,847 granted on 2019-04-09
US20180000749A1
Human necessities

Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

 #5 | 2017-11-02 ✅ Patent 10,167,251 granted on 2019-01-01
US20170313649A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #6 | 2017-10-19 ✅ Patent 10,029,971 granted on 2018-07-24
US20170297991A1
Chemistry; metallurgy

Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols

 #7 | 2017-06-08 ✅ Patent 10,105,325 granted on 2018-10-23
US20170157065A1
Human necessities

Treatment of pervasive developmental disorders with redox-active therapeutics

 #8 | 2017-05-04 ✅ Patent 10,195,161 granted on 2019-02-05
US20170119695A1
Human necessities

Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones

 #9 | 2017-02-09 ✅ Patent 10,071,978 granted on 2018-09-11
US20170037023A1
Chemistry; metallurgy

Process for the production of alpha-tocotrienol and derivatives

 #10 | 2016-08-25 ✅ Patent 9,932,286 granted on 2018-04-03
US20160244392A1
Chemistry; metallurgy

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

 #11 | 2016-02-11 ✅ Patent 9,868,711 granted on 2018-01-16
US20160039776A1
Chemistry; metallurgy

Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders

 #12 | 2016-02-11 ✅ Patent 9,670,170 granted on 2017-06-06
US20160039775A1
Chemistry; metallurgy

Resorufin derivatives for treatment of oxidative stress disorders

 #13 | 2016-01-28 ✅ Patent 10,189,830 granted on 2019-01-29
US20160024085A1
Chemistry; metallurgy

Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders

 #14 | 2015-08-06 ✅ Patent 9,629,815 granted on 2017-04-25
US20150218079A1
Chemistry; metallurgy

Benzoquinone derivatives for treating oxidative stress disorders

 #15 | 2011-11-03 ✅ Patent 10,039,722 granted on 2018-08-07
US20110269776A1
Human necessities

Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells

Also check out BioElectron Technology Corporation's (Mountain View, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

140888 ⎘